Immunogenetics of Multiple Sclerosis

Multiple sclerosis (MS) was one of the first conditions shown to be associated with HLA class II factors. Find the latest research on MS here, including HLA studies providing insights on the genetics of the susceptibility to MS.

January 21, 2021
Open Access

Dysregulated follicular regulatory T cells and antibody responses exacerbate experimental autoimmune encephalomyelitis.

Journal of Neuroinflammation
Lin LuoJianmei W Leavenworth
January 8, 2021
Open Access

Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review

Journal of Translational Medicine
Sija LandmanHans J P M Koenen
December 29, 2020
Open Access

Obesity and the risk of Multiple Sclerosis. The role of Leptin

Annals of Clinical and Translational Neurology
Mariano MarrodanJorge Correale
January 8, 2021

Role of Forkhead box O3a transcription factor in autoimmune diseases

International Immunopharmacology
Shanshan XuFaming Pan
January 16, 2021
Open Access

Synthesis and Pharmacological Evaluation of Fluorinated Quinoxaline-Based κ-Opioid Receptor (KOR) Agonists Designed for PET Studies

Giovanni TangherliniBernhard Wünsch
January 21, 2021
Open Access

Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses.

Neurology. Neuroimmunology and Neuroinflammation
Brian T WipkeRobert H Scannevin
January 14, 2021
Open Access

CCR6 blockade on regulatory T cells ameliorates experimental model of multiple sclerosis

Central-European Journal of Immunology
Izabela Jatczak-PawlikAndrzej Glabinski
December 30, 2020

Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis

Brain : a Journal of Neurology
Kicheol KimSergio E Baranzini
January 6, 2021

Administration of CD4+ CD25high CD127- FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Kamil ChwojnickiPiotr Trzonkowski
January 9, 2021

Immune phenotyping study revealing caveats regarding a switch from fingolimod to cladribine

Multiple Sclerosis and Related Disorders
R F RadlbergerP Wipfler
January 4, 2021

The Potential for Immunospecific Therapy in Multiple Sclerosis Based on Identification of Driver Clones of the Disease

Critical Reviews in Immunology
Claudia Raja GabagliaTodd A Braciak
January 8, 2021
Open Access

Axon-myelin unit blistering as early event in MS normal appearing white matter

Annals of Neurology
Antonio LuchicchiJeroen J G Geurts
December 31, 2020
Open Access

Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease

BMC Research Notes
Arezoo HosseiniBehzad Baradaran
December 29, 2020
Open Access

Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanisms

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Md Yousuf AliMd Asaduzzaman Khan

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved